share_log

ArriVent BioPharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Yi Shi(6.4%),LAV Fund VI, L.P. (“LAVVI”)(6.2%), etc.

SEC announcement ·  Feb 13 17:33
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more